Henry Schein (NASDAQ:HSIC) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Henry Schein (NASDAQ:HSIC) announced its earnings results on Tuesday. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the firm earned $0.66 EPS. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS and its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Stock Down 2.3 %

Henry Schein stock opened at $75.82 on Wednesday. The firm’s 50 day moving average price is $74.25 and its two-hundred day moving average price is $72.43. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.63. The firm has a market cap of $9.45 billion, a PE ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday. Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Eight analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.